Guidelines and definitions for research on epithelial-mesenchymal transition.


Journal

Nature reviews. Molecular cell biology
ISSN: 1471-0080
Titre abrégé: Nat Rev Mol Cell Biol
Pays: England
ID NLM: 100962782

Informations de publication

Date de publication:
06 2020
Historique:
accepted: 11 03 2020
pubmed: 18 4 2020
medline: 21 10 2020
entrez: 18 4 2020
Statut: ppublish

Résumé

Epithelial-mesenchymal transition (EMT) encompasses dynamic changes in cellular organization from epithelial to mesenchymal phenotypes, which leads to functional changes in cell migration and invasion. EMT occurs in a diverse range of physiological and pathological conditions and is driven by a conserved set of inducing signals, transcriptional regulators and downstream effectors. With over 5,700 publications indexed by Web of Science in 2019 alone, research on EMT is expanding rapidly. This growing interest warrants the need for a consensus among researchers when referring to and undertaking research on EMT. This Consensus Statement, mediated by 'the EMT International Association' (TEMTIA), is the outcome of a 2-year-long discussion among EMT researchers and aims to both clarify the nomenclature and provide definitions and guidelines for EMT research in future publications. We trust that these guidelines will help to reduce misunderstanding and misinterpretation of research data generated in various experimental models and to promote cross-disciplinary collaboration to identify and address key open questions in this research field. While recognizing the importance of maintaining diversity in experimental approaches and conceptual frameworks, we emphasize that lasting contributions of EMT research to increasing our understanding of developmental processes and combatting cancer and other diseases depend on the adoption of a unified terminology to describe EMT.

Identifiants

pubmed: 32300252
doi: 10.1038/s41580-020-0237-9
pii: 10.1038/s41580-020-0237-9
pmc: PMC7250738
doi:

Types de publication

Guideline Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

341-352

Subventions

Organisme : NCI NIH HHS
ID : P30 CA016672
Pays : United States
Organisme : NIEHS NIH HHS
ID : P30 ES006694
Pays : United States
Organisme : NICHD NIH HHS
ID : P41 HD088362
Pays : United States
Organisme : NCI NIH HHS
ID : R37 CA232209
Pays : United States
Organisme : Wellcome Trust
ID : 204615/Z/16/Z
Pays : United Kingdom
Organisme : NCI NIH HHS
ID : R01 CA223758
Pays : United States
Organisme : NIDDK NIH HHS
ID : R01 DK119232
Pays : United States
Organisme : NCI NIH HHS
ID : P30 CA023100
Pays : United States

Commentaires et corrections

Type : ErratumIn

Références

Cell. 2017 Feb 9;168(4):670-691
pubmed: 28187288
Nature. 1987 Nov 26-Dec 2;330(6146):395-8
pubmed: 3683556
Science. 2013 Feb 1;339(6119):580-4
pubmed: 23372014
J Cell Sci. 2008 Apr 15;121(Pt 8):1141-50
pubmed: 18388309
Mol Oncol. 2017 Jan;11(1):28-39
pubmed: 28085222
Cancer Res. 2015 May 1;75(9):1789-800
pubmed: 25744723
Oncogene. 2006 Nov 16;25(54):7117-30
pubmed: 16751808
Development. 2011 Jul;138(13):2705-15
pubmed: 21613323
Oncogene. 2005 Mar 31;24(14):2375-85
pubmed: 15674322
Nat Med. 2013 Aug;19(8):1047-53
pubmed: 23817022
Biochim Biophys Acta Rev Cancer. 2017 Dec;1868(2):584-591
pubmed: 28669750
Cancer Cell. 2012 Dec 11;22(6):709-24
pubmed: 23201163
Proc Natl Acad Sci U S A. 2017 Oct 24;114(43):11494-11499
pubmed: 29073077
Nat Cell Biol. 2000 Feb;2(2):84-9
pubmed: 10655587
Nat Rev Cancer. 2012 May 11;12(6):425-36
pubmed: 22576165
Science. 2005 Mar 11;307(5715):1603-9
pubmed: 15761148
Nature. 1994 Dec 15;372(6507):679-83
pubmed: 7990960
Science. 2005 Mar 11;307(5715):1621-5
pubmed: 15761153
Dev Cell. 2015 Aug 24;34(4):421-34
pubmed: 26235046
Dev Cell. 2012 Jan 17;22(1):104-15
pubmed: 22169071
Am J Anat. 1977 Jan;148(1):85-119
pubmed: 842477
Genes Dev. 2013 Oct 15;27(20):2192-206
pubmed: 24142872
Acta Anat (Basel). 1995;154(1):8-20
pubmed: 8714286
Mol Cell. 2001 Jun;7(6):1267-78
pubmed: 11430829
Biochim Biophys Acta. 2008 Mar;1778(3):614-30
pubmed: 18005931
EMBO J. 1988 Jul;7(7):2175-83
pubmed: 3416836
Cell Tissue Res. 1979 Nov;203(1):115-40
pubmed: 509508
Proc Natl Acad Sci U S A. 2012 Oct 16;109(42):16945-50
pubmed: 23027928
Science. 1994 May 6;264(5160):835-9
pubmed: 7513443
Cancer Metastasis Rev. 2016 Dec;35(4):645-654
pubmed: 27878502
Nat Rev Mol Cell Biol. 2002 Mar;3(3):155-66
pubmed: 11994736
Nat Rev Mol Cell Biol. 2016 Feb;17(2):97-109
pubmed: 26726037
Nature. 2015 Nov 26;527(7579):525-530
pubmed: 26560028
PLoS One. 2010 Oct 25;5(10):e13614
pubmed: 21049046
Cancer Res. 2014 Nov 1;74(21):6330-40
pubmed: 25164016
J Cell Biol. 1997 Jun 16;137(6):1403-19
pubmed: 9182671
Nat Rev Mol Cell Biol. 2019 Feb;20(2):69-84
pubmed: 30459476
J Cell Biol. 1994 Dec;127(6 Pt 2):2021-36
pubmed: 7806579
Nat Med. 2015 Sep;21(9):989-97
pubmed: 26236989
Development. 1993 Oct;119(2):433-46
pubmed: 7904558
Oncogene. 2000 Aug 3;19(33):3823-8
pubmed: 10949939
Proc Natl Acad Sci U S A. 1982 Nov;79(21):6737-41
pubmed: 6959151
Nat Cell Biol. 2017 May;19(5):518-529
pubmed: 28414315
Cancer Res. 2005 Jul 15;65(14):5991-5; discussion 5995
pubmed: 16024595
Dev Cell. 2018 Jun 18;45(6):681-695.e4
pubmed: 29920274
Dev Biol. 1989 Aug;134(2):392-401
pubmed: 2744239
J Biol Chem. 2001 Jul 20;276(29):27424-31
pubmed: 11309385
Nature. 2015 Nov 26;527(7579):452-3
pubmed: 26560026
Curr Top Dev Biol. 2015;112:273-300
pubmed: 25733143
Nature. 2011 Apr 21;472(7343):273
pubmed: 21512545
FEBS Lett. 2015 Jun 22;589(14):1577-87
pubmed: 25979173
Nature. 2017 Jul 5;547(7661):E1-E3
pubmed: 28682326
Dev Biol. 1983 Jan;95(1):108-14
pubmed: 6825921
Nat Cell Biol. 2008 Jul;10(7):765-75
pubmed: 18552836
J Cell Sci. 2014 Aug 1;127(Pt 15):3205-15
pubmed: 24994932
Genes Dev. 1991 Sep;5(9):1568-76
pubmed: 1884999
Nat Cell Biol. 2000 Feb;2(2):76-83
pubmed: 10655586
Dev Biol. 1982 Jul;92(1):27-40
pubmed: 7106385
Development. 1992 Sep;116(1):227-37
pubmed: 1483390
Cancer Res. 2005 Jul 15;65(14):5996-6000; discussion 6000-1
pubmed: 16024596
Nat Med. 2007 Aug;13(8):952-61
pubmed: 17660828
Nat Med. 2015 Sep;21(9):998-1009
pubmed: 26236991
Cancer Cell. 2012 Dec 11;22(6):725-36
pubmed: 23201165
J Biol Chem. 1999 Jul 16;274(29):20489-98
pubmed: 10400677
Nature. 2015 Nov 26;527(7579):472-6
pubmed: 26560033
Nat Cell Biol. 2014 Jun;16(6):488-94
pubmed: 24875735
Curr Opin Cell Biol. 2016 Dec;43:7-13
pubmed: 27371787
Nature. 2018 Apr;556(7702):463-468
pubmed: 29670281
J Histochem Cytochem. 2007 Jul;55(7):661-73
pubmed: 17341474
Nat Cell Biol. 2014 Dec;16(12):1146-56
pubmed: 25419850
J Cell Sci. 1985 Aug;77:209-23
pubmed: 3841349
Mech Dev. 2003 Nov;120(11):1351-83
pubmed: 14623443
Development. 2005 Mar;132(6):1187-98
pubmed: 15703282
EMBO J. 2006 Nov 29;25(23):5603-13
pubmed: 17093497
Nature. 1967 Dec 30;216(5122):1349-50
pubmed: 6080074
Cell. 2004 Jun 25;117(7):927-39
pubmed: 15210113
Anat Embryol (Berl). 1995 May;191(5):381-96
pubmed: 7625610
Dev Biol. 2012 Jun 1;366(1):34-54
pubmed: 22261150
J Clin Invest. 2002 Aug;110(3):341-50
pubmed: 12163453
Dev Biol. 1999 Apr 15;208(2):530-45
pubmed: 10191064
Cancer Res. 2002 Mar 15;62(6):1613-8
pubmed: 11912130
Cancer Cell. 2011 Mar 8;19(3):372-86
pubmed: 21397860
Nat Cell Biol. 2019 Mar;21(3):359-371
pubmed: 30804505
J Cell Sci. 2003 Feb 1;116(Pt 3):499-511
pubmed: 12508111
Cell. 2016 Jun 30;166(1):21-45
pubmed: 27368099
Nat Cell Biol. 2019 Jan;21(1):102-112
pubmed: 30602760
Nature. 2017 Jul 5;547(7661):E7-E8
pubmed: 28682339
Mol Oncol. 2017 Jul;11(7):718-738
pubmed: 28590039
Nat Commun. 2015 Aug 14;6:7998
pubmed: 26272476
J Cell Biol. 1982 Oct;95(1):333-9
pubmed: 7142291
Nat Cell Biol. 2015 Apr;17(4):397-408
pubmed: 25812521
Proc Natl Acad Sci U S A. 1990 Feb;87(3):1124-8
pubmed: 2153969

Auteurs

Jing Yang (J)

Departments of Pharmacology and Pediatrics, Moores Cancer Center, University of California, San Diego, La Jolla, CA, USA. jingyang@ucsd.edu.

Parker Antin (P)

Department of Cellular and Molecular Medicine, University of Arizona, Tucson, AZ, USA.

Geert Berx (G)

Molecular and Cellular Oncology Lab, Department of Biomedical Molecular Biology, Ghent University, Cancer Research Institute Ghent (CRIG), VIB Center for Inflammation Research, Ghent, Belgium.

Cédric Blanpain (C)

Laboratory of Stem Cells and Cancer, Université Libre de Bruxelles, Bruxelles, Belgium.

Thomas Brabletz (T)

Department of Experimental Medicine 1, Nikolaus-Fiebiger-Center for Molecular Medicine, Friedrich-Alexander-University Erlangen-Nürnberg, Erlangen, Germany.

Marianne Bronner (M)

Division of Biology and Biological Engineering, California Institute of Technology, Pasadena, CA, USA.

Kyra Campbell (K)

Department of Biomedical Science and Bateson Centre, University of Sheffield, Sheffield, UK.

Amparo Cano (A)

Departamento de Bioquímica, Universidad Autónoma de Madrid (UAM), Instituto de Investigaciones Biomédicas 'Alberto Sols' (CSIC-UAM), IdiPAZ & Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain.

Jordi Casanova (J)

Institute for Research in Biomedicine (IRB Barcelona), Barcelona Institute of Science and Technology/Institut de Biologia Molecular de Barcelona (IBMB-CSIC), Barcelona, Spain.

Gerhard Christofori (G)

Department of Biomedicine, University of Basel, Basel, Switzerland.

Shoukat Dedhar (S)

Department of Biochemistry and Molecular Biology, University of British Columbia and British Columbia Cancer Research Centre, Vancouver, BC, Canada.

Rik Derynck (R)

Departments of Cell and Tissue Biology, and Anatomy, University of California at San Francisco, San Francisco, CA, USA.

Heide L Ford (HL)

Department of Pharmacology, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.

Jonas Fuxe (J)

Department of Laboratory Medicine (LABMED), Division of Pathology, Karolinska University Hospital and Department of Microbiology, Tumor and Cell Biology (MTC), Karolinska Institutet, Stockholm, Sweden.

Antonio García de Herreros (A)

Programa de Recerca en Càncer, Institut Hospital del Mar d'Investigacions Mèdiques (IMIM) and Departament de Ciències Experimentals i de la Salut, Universitat Pompeu Fabra, Barcelona, Spain.

Gregory J Goodall (GJ)

Centre for Cancer Biology, An alliance of SA Pathology and University of South Australia, Adelaide, SA, Australia.

Anna-Katerina Hadjantonakis (AK)

Developmental Biology Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY, USA.

Ruby Y J Huang (RYJ)

School of Medicine, College of Medicine, National Taiwan University, Taipei, Taiwan.

Chaya Kalcheim (C)

Department of Medical Neurobiology, Institute for medical Research Israel-Canada and the Safra Center for Neurosciences, Hebrew University of Jerusalem, Hadassah Medical School, Jerusalem, Israel.

Raghu Kalluri (R)

Department of Cancer Biology, Metastasis Research Center, MD Anderson Cancer Center, Houston, TX, USA.

Yibin Kang (Y)

Department of Molecular Biology, Princeton University, Princeton, NJ, USA.

Yeesim Khew-Goodall (Y)

Centre for Cancer Biology, an Alliance of SA Pathology and the University of South Australia, Adelaide, SA, Australia.

Herbert Levine (H)

Department of Physics, Northeastern University, Boston, MA, USA.

Jinsong Liu (J)

Department of Anatomic Pathology, The Division of Pathology and Laboratory Medicine, University of Texas MD Anderson Cancer Center, Houston, TX, USA.

Gregory D Longmore (GD)

Department of Medicine (Oncology) and Department of Cell Biology and Physiology, ICCE Institute, Washington University, St. Louis, MO, USA.

Sendurai A Mani (SA)

Department of Translational Molecular Pathology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.

Joan Massagué (J)

Cancer Biology and Genetics Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY, USA.

Roberto Mayor (R)

Department of Cell and Developmental Biology, University College London, London, UK.

David McClay (D)

Department of Biology, Duke University, Durham, NC, USA.

Keith E Mostov (KE)

Departments of Anatomy and Biochemistry/Biophysics, University of California, San Francisco, School of Medicine, San Francisco, CA, USA.

Donald F Newgreen (DF)

Murdoch Children's Research Institute, Royal Children's Hospital, Parkville, VIC, Australia.

M Angela Nieto (MA)

Instituto de Neurociencias (CSIC-UMH) Avda Ramon y Cajal s/n, Sant Joan d´Alacant, Spain.

Alain Puisieux (A)

Université Claude Bernard Lyon 1, INSERM 1052, CNRS 5286, Centre Léon Bérard, Cancer Research Center of Lyon, Lyon, France.
Institut Curie, PSL Research University, Paris, France.

Raymond Runyan (R)

Department of Cellular and Molecular Medicine, University of Arizona, Tucson, AZ, USA.

Pierre Savagner (P)

INSERM UMR 1186, Integrative Tumor Immunology and Genetic Oncology, Gustave Roussy, University Paris-Saclay, Villejuif, France.

Ben Stanger (B)

Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.

Marc P Stemmler (MP)

Department of Experimental Medicine 1, Nikolaus-Fiebiger-Center for Molecular Medicine, Friedrich-Alexander-University Erlangen-Nürnberg, Erlangen, Germany.

Yoshiko Takahashi (Y)

Department of Zoology, Graduate School of Science, Kyoto University, Kyoto, Japan.

Masatoshi Takeichi (M)

RIKEN Center for Biosystems Dynamics Research, Kobe, Japan.

Eric Theveneau (E)

Centre de Biologie du Développement (CBD), Centre de Biologie Intégrative (CBI), Université de Toulouse, CNRS, UPS, Toulouse, France.

Jean Paul Thiery (JP)

Guangzhou Regenerative Medicine and Health, Guangdong Laboratory, Guangzhou, China.

Erik W Thompson (EW)

School of Biomedical Sciences and Institute of Health and Biomedical Innovation, Queensland University of Technology, Translational Research Institute, Woolloongabba, QLD, Australia.

Robert A Weinberg (RA)

Whitehead Institute for Biomedical Research, Department of Biology, MIT Ludwig Center for Molecular Oncology, Massachusetts Institute of Technology, Cambridge, MA, USA.

Elizabeth D Williams (ED)

Australian Prostate Cancer Research Centre-Queensland (APCRC-Q) and Queensland Bladder Cancer Initiative (QBCI), School of Biomedical Sciences and Institute of Health and Biomedical Innovation, Queensland University of Technology, Woolloongabba, QLD, Australia.

Jianhua Xing (J)

Department of Computational and Systems Biology and UPMC-Hillman Cancer Center, University of Pittsburgh, Pittsburgh, PA, USA.

Binhua P Zhou (BP)

Department of Molecular and Cellular Biochemistry and UK Markey Cancer Center, University of Kentucky College of Medicine, Lexington, KY, USA.

Guojun Sheng (G)

International Research Center for Medical Sciences (IRCMS), Kumamoto University, Kumamoto, Japan. sheng@kumamoto-u.ac.jp.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH